Stay updated on DECREASE: Dapagliflozin Plus Exenatide Clinical Trial
Sign up to get notified when there's something new on the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page.

Latest updates to the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedRevision: v3.4.2 has been added. The lapse in government funding notice and the prior v3.4.1 revision note were removed, and the revision history was updated.SummaryDifference0.4%

- Check23 days agoChange DetectedA site-wide notice about a lapse in government funding and the NIH Clinical Center’s status, along with a version update from 3.4.0 to 3.4.1, were added.SummaryDifference0.4%

- Check30 days agoChange DetectedA glossary display was added to improve understanding of terms on the study page. In addition, there are minor text and version updates (new QC criteria label and Revision: v3.4.0) and removal of similar old labels.SummaryDifference0.2%

- Check44 days agoChange DetectedThe footer revision notice was updated from v3.3.3 to v3.3.4. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check65 days agoChange DetectedThe page now includes a Locations section with North Holland (Amsterdam UMC, location VUmc); the old North Holland Locations header was removed and the footer HHS Vulnerability Disclosure link was removed, with revision tag updated to v3.3.3.SummaryDifference0.2%

- Check94 days agoChange DetectedThe additions include an automated PubMed publications note and a revision tag (Revision: v3.3.2). The deletions remove the older PubMed note and the previous revision tag (Revision: v3.2.0).SummaryDifference0.1%

Stay in the know with updates to DECREASE: Dapagliflozin Plus Exenatide Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DECREASE: Dapagliflozin Plus Exenatide Clinical Trial page.